Cancer Medicine Journal

Journal Home Editor-in-Chief Editorial Board Articles in Press Current Issue Archive Author Guidelines Submit Manuscript

Home

Cancer Medicine Journal (DOI prefix: 10.46619) (Impact Factor: 3.32) is an International open access, peer-reviewed journal with a broad scope covering all areas of cancer research, especially novel concepts and theories, new methods/techniques, new therapeutic agents, and alternative approaches for early detection and intervention of cancer.

Cancer Medicine Journal focuses to entrench the field of cancer or oncology by publishing articles focused upon disease management, hinderance/prevent, methods for early diagnosis, and specific classes of therapeutic agents, results of a clinical trial, an emerging interventional technique, supportive care, and rehabilitation/reconstruction. Journal provides platform for rapid publication of high quality results in cancer research while maintaining rigorous single blinded peer-review process.

At this stage, the submission and publication of manuscripts is at discount for all students/emeritus professor. The published articles are made freely available to online readers.

Authors Funded by the NIH: This journal automatically deposits papers to PubMed Central after publication of an issue (NIHMS, http://nihms.nih.gov/).

COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC    https://www.coronavirus.gov
Get the latest research    https://www.who.int/emergencies/diseases/novel-coronavirus-2019

Acceptance Rate
64%
Days to process
45
Days to publish
10
Total Articles
91

Recently Published Articles

Review Article | Volume 5, Issue 1 | Open Access
Efficacy of Bamlanivimab in Cancer Patients with COVID-19

Patricia A Brock, Adriana H Wechsler, Anne-Marie Chaftari, Hiba Dagher, Ying Jiang, Demis N Lipe, Patrick Chaftari, Susan Gaeta, Tami Johnson, Daniel Coussirat, Alexandre E Malek, Ray Hachem, and Issam Raad

Research Article | Special Issue | Open Access
Association Between Late-Stage Schistosoma Infection and Colorectal Cancer: A Colorectal Cancer Screening among Elderly People in the Qingpu District of Shanghai Municipal

Xi Yu, Sen Wang, Li Guifu, Xu Ruifang, Kun Xue and Ji Zhu

Case Report | Special Issue | Open Access
An Uncommon Presentation of Obstructive Colonic Cancer: An Extensive Ischemic Colitis

Pattharasai Kachornvitaya and Wasu Sapsupan

Research Article | Special Issue | Open Access
Gastrointestinal Cancers: Racial and Ethnicity Differences

Maharaj Singh, Santhi Konduri, Samit Datta, Wesley Papenfuss, Geoffrey Bellini, Aaron Chevinsky and James Weese

Case Report | Special Issue | Open Access
Genetic Heterogeneity of MTHFR C677T Gene Polymorphism Increase “Risk Factor” Using Circulating Tumor Cells (CTCs) in Acute Lymphoblastic Anemia - A Rare Case Report

Ajit Kumar Saxena

Review Article | Special Issue | Open Access
Pancreatic Cancer Are Resections Justified?

Birgir Gudjonsson

Research Article | Special Issue | Open Access
Mammographic Breast Density Pattern Among Women in Owo, Nigeria

C Adebiyi, AA Egberongbe, CO Omolase and BO Omolase

Review Article | Special Issue | Open Access
Delayed Postoperative Hemorrhage after Pancreaticoduodenectomy

Danilo Coco and Silvana Leanza

Case Report | Volume 5, Issue 3 | Open Access
Synchronous Duodenal and Jejunal Gastrointestinal Stromal Tumors

Andy Petroianu, Kelly Renata Sabino and Michelle Arlete Gonçalves Couto

Review Article | Volume 5, Issue 3 | Open Access
Exosomes Molecular Modifications for Drug Delivery: A Gleam of Hope in the Fight against Glioma

Rohit Singh, Rashmi Rana and Nirmal Kumar Ganguly

View More

Aims & Scope

Main aim of the journal is to improve and share knowledge & global health outcomes by publishing Research article, Review, Case reports to convey important practice messages and best research should be published and made widely accessible as quickly as possible in scientific community. Cancer Medicine Journal welcome all kind of articles covering areas of Cancer Biology, Clinical Cancer Research, Cancer Prevention, and other related fields.

The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:

  • Cancer
  • Cancer Diseases
  • Endocrine disorders
  • Breast cancer
  • Blood diseases
  • Cancer statistics
  • Cancer diagnosis
  • Carcinogenesis - etiology, mechanisms
  • Molecular biology
  • Recent developments in tumor therapy
  • General diagnosis
  • Laboratory diagnosis
  • Diagnostic and experimental pathology
  • Oncologic surgery
  • Epidemiology
  • Treatment strategies
  • Evaluations of current therapies
  • Models for integrating complementary and conventional treatment in clinical practice
  • Interventions from alternative and traditional medicine
  • Implementing quality-of-life assessment and counseling in the clinical setting
  • Cancer rehabilitation during and following cancer treatments
  • Potential interactions of cancer chemotherapy drugs with frequently used dietary supplements
  • Implementing integrative cancer care strategies into oncology practice
  • Relevant molecular mechanisms and biology behind integrative approaches
  • Impact of timing of chemotherapy administration on toxicity
  • Response, and outcome by leading oncologists
  • Researchers, and health-care professionals